You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國際醫學(000516.SZ):已獲批開展第一代體外受精-胚胎移植(IVF-ET)及第二代卵胞漿內單精子顯微注射(ICSI)技術
格隆匯 05-18 11:17

格隆匯5月18日丨國際醫學(000516.SZ)於2023年5月16日下午14:00~17:00召開業績説明會,問答環節中,就“公司一季度生殖業務IVF實施多少例,成功率多少,月子中心入住率多少?”,公司回覆稱,公司已獲批開展第一代體外受精-胚胎移植(IVF-ET)及第二代卵胞漿內單精子顯微注射(ICSI)技術。聘請了輔助生殖領域知名專家作為學科帶頭人,IVF團隊專業技術實力強。自資質獲批以來,已開展了相關業務,目前生殖中心及月子會所正處於加快市場拓展階段。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account